Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination

Tscherne, A; Schwarz, JH; Rohde, C; Kupke, A; Kalodimou, G; Limpinsel, L; Okba, NMA; Bosnjak, B; Sandrock, I; Odak, I; Halwe, S; Sauerhering, L; Brosinski, K; Nan, LL; Duell, E; Jany, S; Freudenstein, A; Schmidt, J; Werner, A; Serra, MG; Kluer, M; Guggemos, W; Seilmaier, M; Wendtner, CM; Forster, R; Haahmans, BL; Becker, S; Sutter, G; Volz, A

Sutter, G (corresponding author), Ludwig Maximilians Univ Munchen, Div Virol, Dept Vet Sci, D-80539 Munich, Germany.; Sutter, G (corresponding author), German Ctr Infect Res, Dept Vet Sci, Div Virol, D-80539 Munich, Germany.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021; 118 (28):

Abstract

Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has emerged as the infectious agent causing the pandemic coronavi-rus disease 2019......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索